BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Zhao Y, Wang S, Li M, Xu Y, Ran J, Geng X, He J, Meng J, Shao G, Zhou H, Ge Z, Chen G, Li R, Yang B. Discovery of novel diarylamides as orally active diuretics targeting urea transporters. Acta Pharm Sin B 2021;11:181-202. [PMID: 33532188 DOI: 10.1016/j.apsb.2020.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Y, Zhang H, Li N, Ma W, Wang S, Sun J, Yang B. Preclinical Pharmacokinetic Studies of a Novel Diuretic Inhibiting Urea Transporters. Molecules 2022;27:2451. [PMID: 35458649 DOI: 10.3390/molecules27082451] [Reference Citation Analysis]
2 Amin SA, Nandi S, Kashaw SK, Jha T, Gayen S. A critical analysis of urea transporter B inhibitors: molecular fingerprints, pharmacophore features for the development of next-generation diuretics. Mol Divers 2022. [PMID: 34978011 DOI: 10.1007/s11030-021-10353-w] [Reference Citation Analysis]
3 Wang S, Xu Y, Zhao Y, Zhang S, Li M, Li X, He J, Zhou H, Ge Z, Li R, Yang B. N-(4-acetamidophenyl)-5-acetylfuran-2-carboxamide as a novel orally available diuretic that targets urea transporters with improved PD and PK properties. Eur J Med Chem 2021;226:113859. [PMID: 34601246 DOI: 10.1016/j.ejmech.2021.113859] [Reference Citation Analysis]
4 Agarwal S, Sudhini YR, Polat OK, Reiser J, Altintas MM. Renal cell markers: lighthouses for managing renal diseases. Am J Physiol Renal Physiol 2021;321:F715-39. [PMID: 34632812 DOI: 10.1152/ajprenal.00182.2021] [Reference Citation Analysis]
5 Nandi S, Sanyal S, Amin SA, Kashaw SK, Jha T, Gayen S. Urea transporter and its specific and nonspecific inhibitors: State of the art and pharmacological perspective. Eur J Pharmacol 2021;911:174508. [PMID: 34536365 DOI: 10.1016/j.ejphar.2021.174508] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]